• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Detection of renal tubular lesions after abdominal aortography and selective renal arteriography by quantitative measurements of brush-border enzymes in the urine.

作者信息

Hartmann H G, Braedel H E, Jutzler G A

出版信息

Nephron. 1985;39(2):95-101. doi: 10.1159/000183351.

DOI:10.1159/000183351
PMID:2858067
Abstract

Quantitative determination of brush-border enzyme excretion in the 24-hour urine is a much more sensitive index of renal tubular damage after aortography and selective renal arteriography than the conventional renal function tests such as serum creatinine and clearance determinations. Among the five brush-border enzymes which we investigated, alkaline phosphatase (AP) was the most sensitive diagnostic pointer. In 90% of hypertensive patients without detectable pre-existing renal parenchymal damage, abnormal levels of AP excretion in the urine were found on the same day as or on the day after the intra-arterial injection of contrast medium. Measurement of other brush-border enzymes does not provide any further diagnostic information. Provided there is no pre-existing renal parenchymal damage, the lesion caused by the contrast medium is transient and is usually reversed within 48 h. For the early detection of tubular lesions caused by tri-iodinated benzoic acid derivatives, AP excretion in the 24-hour urine should be measured at least twice--on the day of the contrast medium injection and on the following day.

摘要

相似文献

1
Detection of renal tubular lesions after abdominal aortography and selective renal arteriography by quantitative measurements of brush-border enzymes in the urine.
Nephron. 1985;39(2):95-101. doi: 10.1159/000183351.
2
Urinary excretion of renal brush-border enzymes in lepromatous leprosy--a preliminary investigation.瘤型麻风患者肾刷状缘酶的尿排泄——一项初步研究。
Int J Lepr Other Mycobact Dis. 1989 Mar;57(1):20-3.
3
Quantitative enzymuria following aorto-renal angiography.主动脉-肾动脉血管造影术后的定量酶尿
J Assoc Physicians India. 1999 Feb;47(2):189-91.
4
Urinary excretion of renal brush border membrane enzymes in leprosy patients--effect of multidrug therapy.
Experientia. 1996 Feb 15;52(2):127-30. doi: 10.1007/BF01923356.
5
[Urinary enzyme excretion in cephalothin therapy in pregnancy].
Zentralbl Gynakol. 1985;107(2):90-7.
6
Nephrotoxicity of ioxaglate and ioversol assessed by glomerular filtration rate: a pilot study.通过肾小球滤过率评估碘克沙醇和碘海醇的肾毒性:一项初步研究。
Can Assoc Radiol J. 1996 Feb;47(1):24-9.
7
Enzymuria after administration of water-soluble X-ray contrast media.水溶性X线造影剂给药后的酶尿症
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1983;118:30-6.
8
Lysosomal and brush border membrane enzymes in urine of patients with renal artery stenosis and with essential hypertension.
Clin Biochem. 1979 Dec;12(6):228-20. doi: 10.1016/s0009-9120(79)80110-1.
9
[Nephrotoxicity of ionic and nonionic contrast media in selective renovasography].[离子型与非离子型造影剂在选择性肾血管造影中的肾毒性]
Urologe A. 1986 Mar;25(2):120-3.
10
Urinary beta-2-microglobulin determinations in assessment of tubular dysfunction after X-ray contrast media application.应用X射线造影剂后尿β2微球蛋白测定对肾小管功能障碍的评估
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1983;118:43-9.

引用本文的文献

1
Bicarbonates for the prevention of postoperative renal failure in endovascular aortic aneurysm repair: a randomized pilot trial.
Anesthesiol Res Pract. 2013;2013:467326. doi: 10.1155/2013/467326. Epub 2013 Jun 12.
2
Biomarkers in Acute Kidney Injury.急性肾损伤中的生物标志物
Biomark Insights. 2008 Feb 26;3:115-125. doi: 10.4137/bmi.s450.
3
Biomarkers of acute kidney injury.急性肾损伤的生物标志物
Adv Chronic Kidney Dis. 2008 Jul;15(3):222-34. doi: 10.1053/j.ackd.2008.04.003.
4
Urine proteomics: the present and future of measuring urinary protein components in disease.尿液蛋白质组学:疾病中测量尿液蛋白质成分的现状与未来
CMAJ. 2007 Aug 14;177(4):361-8. doi: 10.1503/cmaj.061590.